Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction.
about
Human conditions of insulin-like growth factor-I (IGF-I) deficiencyGIT2 acts as a potential keystone protein in functional hypothalamic networks associated with age-related phenotypic changes in ratsNADPH oxidases: key modulators in aging and age-related cardiovascular diseases?Quality control systems in cardiac agingAltered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart.Cardiac aging in mice and humans: the role of mitochondrial oxidative stressThe GH/IGF-1 axis in ageing and longevityA novel AMPK activator from Chinese herb medicine and ischemia phosphorylate the cardiac transcription factor FOXO3.Deficiency of insulin-like growth factor 1 reduces vulnerability to chronic alcohol intake-induced cardiomyocyte mechanical dysfunction: role of AMPKPeroxisome proliferator-activated receptor γ coactivator 1α and FoxO3A mediate chondroprotection by AMP-activated protein kinase.Insulin-like growth factor I (IGF-1) deficiency ameliorates sex difference in cardiac contractile function and intracellular Ca(2+) homeostasisCardiac aging: from molecular mechanisms to significance in human health and diseaseThe emerging role of IGF-1 deficiency in cardiovascular aging: recent advancesDeletion of IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice.Alpha1 catalytic subunit of AMPK modulates contractile function of cardiomyocytes through phosphorylation of troponin I.The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future ResearchThe Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2.Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemiaThe role of liver-derived insulin-like growth factor-I.Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system.The Aging HeartMitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function.GsMTx4-D is a cardioprotectant against myocardial infarction during ischemia and reperfusion.AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunctionNatural antioxidant-isoliquiritigenin ameliorates contractile dysfunction of hypoxic cardiomyocytes via AMPK signaling pathway.Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy.
P2860
Q26822806-3E8E654B-613A-4F58-8BD2-050E5CBC3A38Q27302985-F518A138-C2D2-4C3F-ACDF-405DFC6416EEQ28072348-17322BE7-F51E-45B9-8641-0AA89F52E92EQ28084341-A6258691-1C28-480D-BA3D-A8D2470686DBQ33692414-7014914A-FACA-474E-AA8F-3092D9F5674BQ33806910-4ADB5008-E785-4735-A05A-C51A1CA713AAQ33817029-83476F1D-95AC-45FD-A485-33355A3D2088Q33825443-995D64F3-9499-47DC-A4E6-0B2982B08885Q34474751-F008B95B-55FB-4DAF-96CD-0747594F238CQ35128583-4625D091-497E-4EA3-89B8-3F69ED274948Q35186280-5EACE9F0-D76D-461B-8864-37B40D88560DQ35898648-29F4678F-204C-455E-B60F-AFFE7173476EQ35947431-9D13F5BA-7711-457C-9E35-1F4ADBAE00B9Q36431795-3B2C924F-2814-4772-B308-1A1DAD41590AQ36649084-172AEB5B-DFF8-4E38-8CC4-2DEA7C2D0B0CQ37035744-1B842A2F-6C04-4571-B67E-831FB83AB529Q37228131-594BDEEB-6BDC-4722-9A5B-4CA1332C60B5Q37310637-288C2651-5C25-479D-A48C-E544F05756F8Q37381848-77DEBCCE-BA43-4D9B-AE4F-89E7BD4EA3C6Q37442678-D1F174BD-1765-420F-A495-AE53252A48A9Q38571586-E035363B-ADEB-4E30-BE9C-F36A6AE5EE71Q38578328-4A0B4E67-3300-47C6-8FEE-D7DE5F25F08DQ41089202-FFB9480F-E42C-47B4-A10D-F4ED34EF15EFQ41112302-7CD593E5-5C63-4C34-8DB9-B5991AF74838Q42154599-2504CF13-0B3D-4ADE-B2BF-9F2FB90901DFQ42954804-E7DA6301-AEF7-4594-B219-6AB8E81484A4Q54562272-9B5628E2-1953-4D80-B13F-B46840D130BE
P2860
Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Deficiency of insulin-like gro ...... ted cardiomyocyte dysfunction.
@ast
Deficiency of insulin-like gro ...... ted cardiomyocyte dysfunction.
@en
Deficiency of insulin-like gro ...... ted cardiomyocyte dysfunction.
@nl
type
label
Deficiency of insulin-like gro ...... ted cardiomyocyte dysfunction.
@ast
Deficiency of insulin-like gro ...... ted cardiomyocyte dysfunction.
@en
Deficiency of insulin-like gro ...... ted cardiomyocyte dysfunction.
@nl
prefLabel
Deficiency of insulin-like gro ...... ted cardiomyocyte dysfunction.
@ast
Deficiency of insulin-like gro ...... ted cardiomyocyte dysfunction.
@en
Deficiency of insulin-like gro ...... ted cardiomyocyte dysfunction.
@nl
P2093
P2860
P356
P1476
Deficiency of insulin-like gro ...... ted cardiomyocyte dysfunction.
@en
P2093
P2860
P304
P356
10.1089/REJ.2008.0717
P407
P577
2008-08-01T00:00:00Z